Plasma Cell Regulation by Purinergic Receptors
Plasma Cell Regulation by Purinergic Receptors
批准号:
10441466
负责人:
David M Allman
金额:
$20.31万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-01 至 2024-06-30
关键词:
ATP ReceptorsAntibodiesAntibody titer measurementAutoantigensAutoimmune DiseasesAutoimmunityB-LymphocytesBindingBone GrowthBone MarrowCD8-Positive T-LymphocytesCartilageCationsCell CountCell MaintenanceCell SurvivalCell physiologyCellsChondrocytesChronicClinicalConnexinsDataDefectElementsExhibitsExtracellular SpaceFamilyG-Protein-Coupled ReceptorsGenerationsGraft RejectionHealthHumanImmunoglobulin-Secreting CellsInduced MutationKnockout MiceLongevityMaintenanceMembraneMemoryMessenger RNAMolecularMutant Strains MiceOdontoblastsOsteoblastsPathogenicityPharmaceutical PreparationsPlasma CellsPoisonPurinoceptorRegulationRoleSerumSignal PathwaySignal TransductionSpleenTestingTissuesTooth structureTransplantationVaccine DesignVertebratesWorkbasebonechronic painextracellularimmune activationimprovedimproved outcomeinhibitorinsightmembermineralizationmutantnovelnovel strategiesnovel therapeutic interventionnovel therapeuticsosteoblast differentiationplasma cell differentiationpyridoxal phosphate-6-azophenyl-2&apos,4&apos-disulfonic acidreceptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary
Plasma cells that secrete antibodies against self-antigens pose a considerable threat to
human health. Moreover, because many plasma cells are exceptionally long-lived,
strategies are needed to deplete long-lived plasma cells (LLPCs) that secrete pathogenic
antibodies. This project centers on the hypothesis that LLPCs in bone marrow generate
requisite survival signals by sensing extracellular ATP with specific members of the
purinergic receptor (P2rX) family. Hence, we propose that compounds that selectively
poison relevant purinergic receptors will deplete LLPCs. To test our hypothesis, we will:
1) Establish the impact of P2rX inhibitors on LLPC generation and maintenance, and 2)
Determine the role of the purinergic receptor P2rX4 in early plasma cell induction and
LLPC maintenance. These studies will provide unique and needed insights into the
specialized survival mechanisms employed by LLPCs. This work supports our long-term
objective of developing strategies to effectively and specifically disable or deplete
problematic plasma cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biochemical Mechanisms for Sustained Humoral Immunity
-
批准号:10637251
-
项目类别:
-
资助金额:$64.81万
-
财政年份:2023
-
负责人:David M Allman
-
依托单位:
The Notch Pathway in Antigen Design
-
批准号:10575892
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2023
-
负责人:David M Allman
-
依托单位:
Plasma Cell Regulation by Purinergic Receptors
-
批准号:10240081
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2021
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10215534
-
项目类别:
-
资助金额:$69.17万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10443660
-
项目类别:
-
资助金额:$68.88万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10652461
-
项目类别:
-
资助金额:$65.66万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Plasma Cell Priming
-
批准号:9403332
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2017
-
负责人:David M Allman
-
依托单位:
Epigenetic Control of Plasma Cell Differentiation
-
批准号:9105812
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2015
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9111850
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9315100
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:8772548
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8387887
-
项目类别:
-
资助金额:$38.93万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8680129
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8508182
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:9096003
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8868901
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:8066726
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:7983146
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7812028
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7268827
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
海外基金